Inventor · disambiguated record
Michael Dickes
Also filed as: DICKES MICHAEL
23 granted patents·5 pending applications·796 citations·filing 1989–2021
98Inventor score
Files withABBVIE BIOTECHNOLOGY LTD23ABBVIE BIOTENCHOLOGY LTD1DEUTSCHES KREBSFORSCH1KRAUSE HANS-JUERGEN1KRUASE HANS-JUERGEN1
Top patents by PatentIndex Score
28 records- 0199US9114166B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 25, 2015·67 cites·30 claims
- 0299US8916157B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 23, 2014·91 cites·30 claims
- 0398US9738714B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Aug 22, 2017·22 cites·30 claims
- 0498US9272041B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·30 cites·30 claims
- 0598US8940305B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jan 27, 2015·27 cites·30 claims
- 0698US8916158B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 23, 2014·31 cites·30 claims
- 0798US8911741B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 16, 2014·26 cites·30 claims
- 0898US8802101B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Aug 12, 2014·35 cites·29 claims
- 0998US8795670B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Aug 5, 2014·27 cites·29 claims
- 1097US9327032B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted May 3, 2016·17 cites·30 claims
- 1197US9302011B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Apr 5, 2016·17 cites·30 claims
- 1297US9295725B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 29, 2016·17 cites·30 claims
- 1397US9289497B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 22, 2016·17 cites·30 claims
- 1497US9272042B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·17 cites·30 claims
- 1597US9220781B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Dec 29, 2015·19 cites·30 claims
- 1697US8802102B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 12, 2014·26 cites·29 claims
- 1796US9750808B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Sep 5, 2017·10 cites·30 claims
- 1896US8802100B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTENCHOLOGY LTD·Filed 2013·Granted Aug 12, 2014·65 cites·29 claims
- 1995US9950066B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Apr 24, 2018·8 cites·20 claims
- 2095US9732152B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Aug 15, 2017·8 cites·30 claims
- 2195US8932591B2Formulation of human antibodies for treating TNF-α associated disordersKRAUSE HANS-JUERGEN·Filed 2012·Granted Jan 13, 2015·30 cites·48 claims
- 2294US8216583B2Formulation of human antibodies for treating TNF-α associated disordersKRUASE HANS-JUERGEN·Filed 2003·Granted Jul 10, 2012·147 cites·19 claims
- 2387US5622936ATumor inhibiting saccharide conjugatesDEUTSCHES KREBSFORSCH·Filed 1989·Granted Apr 22, 1997·42 cites·10 claims
- 2482US2022241415A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2021·Application pending·0 cites
- 2579US2021113694A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 2674US2018339046A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 2773US2019054171A1Formulation of human antibodies for treating tnf-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2018·Application pending·0 cites
- 2858US2004033228A1Formulation of human antibodies for treating TNF-alpha associated disordersFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Dickes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →